Photodynamic Therapy for Human Papilloma Virus-Related Diseases in Dermatology
暂无分享,去创建一个
[1] H. Hausen,et al. Human Pathogenic Papillomaviruses , 1994, Current Topics in Microbiology and Immunology.
[2] Martin Kriegmair,et al. CELLULAR FLUORESCENCE OF THE ENDOGENOUS PHOTOSENSITIZER PROTOPORPHYRIN IX FOLLOWING EXPOSURE TO 5‐AMINOLEVULINIC ACID , 1995, Photochemistry and photobiology.
[3] M. Landthaler,et al. [Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[4] N. Christensen,et al. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus , 1996, Journal of virology.
[5] Z. Malik,et al. Treatment of viral infections with 5‐aminolevulinic acid and light , 1997, Lasers in surgery and medicine.
[6] K. Specht. THE ROLE OF DNA DAMAGE IN PM2 VIRAL INACTIVATION BY METHYLENE BLUE PHOTOSENSITIZATION , 1994, Photochemistry and photobiology.
[7] A. Ferenczy,et al. Latent papillomavirus and recurring genital warts. , 1985, The New England journal of medicine.
[8] R. G. Frank,et al. Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. , 1996, Genitourinary medicine.
[9] N. Kollias,et al. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5‐aminolaevulinic acid: implications for photodynamic treatment , 1997, The British journal of dermatology.
[10] A. Ferenczy,et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. , 1998, Archives of dermatology.
[11] L. Braathen,et al. Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.
[12] J. Lenard,et al. PHOTOINACTIVATION OF INFLUENZA VIRUS FUSION AND INFECTIVITY BY ROSE BENGAL , 1993, Photochemistry and photobiology.
[13] C. Lytle,et al. Photodynamic therapy for herpes simplex: a critical review. , 1979, Pharmacology & therapeutics.
[14] A. Pardee,et al. Photodynamic inactivation of free and vegatative bacteriophage T4. , 1967, Biochimica et biophysica acta.
[15] S. Iinuma,et al. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.
[16] E. Ben-hur,et al. Silicon Phthalocyanine Pc 4 and Red Light Causes Apoptosis in HIV‐infected Cells , 1997, Photochemistry and photobiology.
[17] S. Spruance,et al. Treatment of genital warts with an immune-response modifier (imiquimod). , 1998, Journal of the American Academy of Dermatology.
[18] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[19] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[20] E. Villiers. Human Pathogenic Papillomavirus Types: An Update , 1994 .
[21] Christian Gluud,et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.
[22] M. Korbelik,et al. Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[23] M W Berns,et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. , 1996, American journal of obstetrics and gynecology.
[24] A. Ferenczy. Laser treatment of genital human papillomavirus infections in the male patient. , 1991, Obstetrics and gynecology clinics of North America.
[25] B. Lambrecht,et al. Photoinactivation of Viruses in Human Fresh Plasma by Phenothiazine Dyes in Combination with Visible Light , 1991, Vox sanguinis.
[26] L. Koutsky. Epidemiology of genital human papillomavirus infection. , 1997, The American journal of medicine.
[27] W. Sluiter,et al. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. , 1997, Cancer research.
[28] S. Jabłońska,et al. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. , 1995, Archives of dermatology.
[29] B. Henderson,et al. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.
[30] I. Stender,et al. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.
[31] B. Ortel,et al. Photodynamic therapy and fluorescence diagnosis in dermatology , 2001 .
[32] M. Lutzner,et al. Interferon and retinoid treatment of warts. , 1985, Clinics in dermatology.
[33] J. D. Christensen,et al. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. , 1985, Genitourinary medicine.
[34] W. Stolz,et al. Epidermodysplasia verruciformis treated using topical 5‐aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.
[35] A. Ferenczy,et al. Therapeutic approaches to genital warts. , 1997, The American journal of medicine.